Literature DB >> 19289476

Diagnosis and new treatment in muscle channelopathies.

G Meola1, M G Hanna, B Fontaine.   

Abstract

The skeletal muscle fibre membrane plays a major role in muscle contraction by generating and propagating action potentials, and linking the latter to the release of intracellular calcium stores which triggers mechanical contraction. This function relies on the proper functioning of ion channels. In the last two decades, diseases caused by mutations in muscle ion channel genes have been identified, the so-called muscle channelopathies. Even though the pathophysiology of muscle channelopathies is not completely elucidated, major advances have been made in their understanding, thus linking patient symptoms and neurophysiology with abnormal functioning of the muscle membrane. This has facilitated significant progress both in the diagnosis of these disorders and in the rationale for therapeutic intervention. In this review, we will focus on diagnosis and treatments of muscle channelopathies of relevance to the clinical neurologist.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19289476     DOI: 10.1136/jnnp.2008.164046

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  The cognitive impact of the ANK3 risk variant for bipolar disorder: initial evidence of selectivity to signal detection during sustained attention.

Authors:  Gaia Ruberto; Evangelos Vassos; Cathryn M Lewis; Roberto Tatarelli; Paolo Girardi; David Collier; Sophia Frangou
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

2.  The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis.

Authors:  Xiaobing Li; Sheng Yao; Yining Xiang; Xiaolei Zhang; Xiangbing Wu; Laimin Luo; Haihua Huang; Min Zhu; Hui Wan; Daojun Hong
Journal:  BMC Neurol       Date:  2015-03-21       Impact factor: 2.474

3.  Rare KCNJ18 variants do not explain hypokalaemic periodic paralysis in 263 unrelated patients.

Authors:  Marius Kuhn; Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-16       Impact factor: 10.154

4.  Phenotypical Variation with Same Genetic Mutation in Familial Hypokalemic Periodic Paralysis.

Authors:  Sumant Kumar; Eniang E Offiong; Sweta Sangita; Nahin Hussain
Journal:  J Pediatr Neurosci       Date:  2018 Apr-Jun

5.  Flecainide-Induced Brugada Syndrome in a Patient With Skeletal Muscle Sodium Channelopathy: A Case Report With Critical Therapeutical Implications and Review of the Literature.

Authors:  Michele Cavalli; Barbara Fossati; Raffaele Vitale; Elisa Brigonzi; Vito A G Ricigliano; Lorenzo Saraceno; Rosanna Cardani; Carlo Pappone; Giovanni Meola
Journal:  Front Neurol       Date:  2018-05-30       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.